# Faeth Therapeutics, Inc.: Form 8-K, filed Dec 8, 2022

- Company: [Faeth Therapeutics, Inc.](/companies/fth.md) (CIK 1829802)
- Form: 8-K
- Filed: 2022-12-08
- Accepted by EDGAR: Dec 8, 2022, 08:18 ET
- Period: 2022-12-05
- Accession: 0001193125-22-300545
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1829802/000119312522300545/d431901d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1829802/000119312522300545/

## Items reported

- Item 2.05: Exit or disposal costs
- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1829802/000119312522300545/d431901d8k.htm

Filed Dec 8, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-300545. Last ingested by Listed: Nov 3, 2026, 23:17 ET. No prices; not investment advice.